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Summary.-The gut microcolony assay has been used to measure damage to
intestinal crypts by single and split doses of 3 alkylating agents: mechlorethamine
hydrochloride (HN2), bis-chloroethyl-nitrosourea (BCNU) and isopropyl methane
sulphonate (IMS). The single-dose survival curvesforwhole crypts weredistinguished
by extrapolation numbers (3-0, 176 and 15 respectively) that were lower than most
previously published values for assay by irradiation. Significant sparing of crypts
occurred when doses of HN2 or BCNU, but not IMS, were given in 2 equal fractions
separated by more than 2 h. Deduced Do values for those cells from which crypts
regenerate were 1*9 mg/kg HN2, 19 mg/kg BCNU and 487 mg/kg IMS.
THE INTESTINAL-CRYPT MICROCOLONY
ASSAY (Withers & Elkind, 1970) isgenerally
held to measure the response to treatment
of a population of epithelial cells (crypto-
genic cells) each of whose members is
capable of regenerating an entire crypt.
Hagemann etal. (197la)havesuggestedthat
these cells might be synonymous with the
proliferative fraction of crypt cells, which
number -,150 per murine jejunal crypt,
as assayed by uptake of 3H-thymidine.
A similar estimate (140) has recently been
obtained for numbers of cryptogenic cells
per crypt (Masuda et al., 1977). If this
equation of the 2 populations is tenable,
2 distinct experimental approaches are
available for assay of damage to the same
cells of the jejunal epithelium. However,
other workers have reported mean num-
bers of cryptogenic cells consistently
lower than those of the proliferative
fraction (e.g. 86; Potten & Hendry, 1975).
To our knowledge, all such estimates have
been derived from the results of crypt
depletion by ionizing radiation. Examina-
tion of the effects of cytotoxic agents
other than radiation are of interest, both
from the fundamental aspect, and because
the literature now contains several
references to the combined effects of cyto-
toxic drugs and radiation doses (e.g.
Phillips et al., 1975; Boarder & Blackett,
1976; Moore & Hendry, 1978). In the
latter case, 2 questions may be asked
that bear on the interpretation of experi-
mental results: (1) do the 2 agents used in
the combination share the same quanti-
tative target population; and (2) are the
shapes ofsurvival curves for relatively low
doses of cytotoxic drugs plus radiation
doses predictive for the response to the
larger doses of drug required to produce
the end-point of crypt depletion? We
report here our initial findings with the gut
microcolony assay for each of 3 alkylating
agents, injected i.p. as in the studies cited
above.
MATERIALS AND METHODS
Male B6D2F,(Pat) mice, aged 9-11 weeks,
were used at a mean weight of 28-5g. The
animals were kept under a 12-h dark
(18.00-06.00h), 12-h light regimen, and were
given food and water ad libitum.
Drugs -1. Mechlorethamine hydrochloride
(HN2, Boots, Nottingham) was dissolved in
sterile water. Graded single doses were in-
jected at 09.00 h. For split-dose experiments,
2 equal doses were given, the first at 09.00 h
and the second at intervals up to 6 h and at
24 h later.J. V. MOORE
(2) 1,3 - bis(2 - chloroethyl) - 1 - nitrosurea
(BCNJ,NIH, Bethesda,U.S.A.) wasdissolved
initially in ethanol and diluted in sterile
water. Single doses were given at 09.00 h; the
second injection in split-dose experiments, up
to 6 h later.
(3) Isopropyl methane sulphonate (IMS,
Koch-Light,Colnbrook),whichhadbeenstored
at-20°Cuntil just before use, wasthawedand
diluted in sterile Hanks' solution. Single
doses were given at 09.00 h, split doses at
09.00 and at up to 24 h later.
The effect of a drug depends on both the
concentration and the time for which the
target cells are exposed to the agent. This
can influence, for example, the results of
split-dose experiments. Forthisreason, agents
were chosen of short half-life. Published
values for IMS (Ross, 1962) and for HN2
(Nadkarni et al., 1956) are of the order of
minutes, while the cytotoxicity of BCNU is
negligible after the first hour (Chirigos et al.,
1965). All drug solutions were made up
immediately before use, and dilutions were
carried out in the appropriate solvent to give
a standard i.p. injection volume of 0 4 ml.
Drug doses injected in this volume are quoted
as mg/kg of body weight.
Irradiation.-A 137Cs y-ray unit was used,
in which mice received whole-body single
doses of 600-1500 rad, at a dose rate of 500
rad/min. In a split-dose radiation experiment,
a first dose of 1000 rad given at 09.00 h was
followed 1-6 h later by a second dose of
500 rad. During these irradiations, the un-
anaesthetized mice were constrained within
Perspex tubes.
Assay and analysis of results.-Three
animals were used per experimental point.
Each experiment was repeated at least once
and the data were pooled. In these experi-
ments, mice were killed 3-5 days after IMS,
4 days after HN2 and BCNU. The surviving
fraction of crypts after treatment was calcu-
lated relative to the mean number of crypts
per jejunal circumference in untreated
animals (117). Regenerating crypts are often
larger than unstimulated crypts, so a correc-
tion factor has been applied to allow for the
greater probability of encountering a crypt
of large diameter in a section of a given
thickness (Hendry & Potten, 1974). Assuming
that the numbers of surviving cryptogenic
cells per crypt form a Poisson distinction
(Withers & Elkind, 1970), then from data on
the survival of whole crypts calculation can
be made of the overall extrapolation number
(taken as to equal the number of cryptogenic
cells per crypt multiplied by the cell extra-
polation number) and of the slope (1/Do) of
the survival curve of cryptogenic cells
(Gilbert, 1969, 1974).
In the combined-modality experiments, a
range ofsingle doses ofeach drug was injected
at 09.00 h. The largest dose in each series was
the approximate 30-day LD10 dose for these
mice. A test dose of 1000 rad of y-rays was
given 6 h later. This interval was used be-
cause Roberts et al. (1971) have shown for
mammalian cells in vitro that repair of sub-
lethal damage by alkylating agents should be
largely complete by this time. The possibility
of interaction between the 2 sets of damage
may be thereby reduced. The mice were
killed at 3-5 or 4 days, as in the single-agent
experiments. From the slopes of curves for
crypt survival after graded doses of drugs
plus a fixed dose of radiation, the sensitivity
(Do) of cryptogenic cells to tolerated doses of
the drugs can be estimated (Moore & Hendry,
1978).
RESULTS
Single agent
HN2.-Single doses ablated increasing
numbers of jejunal crypts as the injected
dose was increased, giving a crypt-survival
curve whose shape was a modified expo-
nential (Fig. IA). The threshold dose was
-2*5 mg/kg. Values of other parameters
derived from the curve are given in the
Table, Section A. For split-dose experi-
ments, 4 mg/kg was chosen as the first
dose, being just on the exponential part of
the survival curve for whole crypts. With
a second dose of 4 mg/kg, the surviving
fraction ofcrypts at firstdecreased relative
to a single dose of 8 mg/kg, although not
significantly, then increased until at 6 h
the relative survival ("Recovery Factor",
RF) was 4-7 (Fig. iB). The maximum RF
is taken to equal the cell extrapolation
number (Hendry & Potten, 1974). The
use ofthe parameter RF assumes that, for
all 3 drugs, cellular sensitivity does not
alter radically during the period of
recovery.
BCNU.-The response of BCNU was
distinguished from that of HN2 by a more
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FIG. 1. (A) Surviving fraction of whole
jejunal crypts relative to numbers in un-
treated animals 4 days after treatment by
single doses of mechlorethamine hydro-
chloride, HN2. Curves drawn according to
the results from a probit fitting pro-
gramme.
(B) Surviving fraction of crypts 4 days after
the second of 2 doses of 4 mg/kg HN2,
injected up to 24 h apart. Relative survival
(=Recovery Factor) expressed as the ratio
ofcrypt survival for split doses to that after
the same total dose given as a single
injection. Errors as -1-2 s.e.
pronounced shoulder on the single-dose
survival curve for whole crypts (Fig. 2A)
but also by a greater capacity for recovery
between doses (Fig. 2B). In calculating
numbers of cryptogenic cells, the
maximum (4 h) RF was used (Table,
Section A). The subsequently lower RF
values might reflect progression of sur-
vivors through the cell cycle, as seen after
irradiation of crypts (Hagemann et al.,
1971b), so that the assumption of un-
changed sensitivity may not be entirely
valid in this case.
IMS. The computed curve for single
doses of this drug (Fig. 3A) was a poor fit
to the data for the highest doses used,
because these were assigned relatively
little weight by the fitting programme
(Gilbert, 1969). However, recalculation
from the data without using weights
yielded an overall extrapolation number
of 2-5, not significantly different from the
computed value (Table, Section A). No
change in crypt survival occurred with
split doses (Fig. 3B) so that the overall
extrapolation number also represented the
number of cryptogenic cells per crypt.
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TABLE. Cell survival paramneters (±s.e.)for cryptogenic cells, derivedfronm curves ofcrypt
survival
Overall
extra-
polation
number Agenit
A. Single agent
HN2
BCNIJ
MAIS
MIaximumn Cryptogenic
recovery cells
factor per crypt
3 -0± 1-8 4- 70-9 0-6+0-6
-0-4
176 ±47 28 ±2 6- 3+2- 3
-2-0
1-5±i 1-4 1 * 0A0 +1 1 * a± ±1 7
1-4
B. Combined modalities
HN2 (0.5 5-5 0 mg/kg)6 hb 1000 rad
BCNU (10 100 mg/kg) 6h h1000 rad
IMS (25--275 mg/kg) 6 h-1000 rad
Do (mg/k-g)
1-9-- 0-2
19 ± 4
487 ±143
1-1± 0-1
:1 6
316 + 59
ablated was very large (700 r). The
derived Do for the exponential portion of
the survival curve for cryptogenic cells was
136±10 rad. The mean overall extra-
polation number was 1075, markedly
higher than for any of the drugs. When
split doses were given as 1000 r and 500 r
separated by 1-6-hintervals, the maximum
(5 h) RF was 15±4. The number ofcrypto-
genic cells per crypt would thus lie between
60 and 100.
Combined modalities
12 I I l l For all 3 alkylating agents, as the dose
0 200 600 1000 of drug used in the combination increased,
IMS dose (mg/kg) B so the surviving fraction of crypts de- 4B creased. The curves fitted to the data were
3- monophasic, with their origin at, or close
2- to, the surviving fraction for 1000 rad
alone (Fig. 4). From these curves, Do
1 + values were derived for cryptogenic cells
08 I 1 (Table, Section B). Note that the Dos for
06 - the tolerated doses of drug and those for
04D 2 4 / the higher, lethal doses required to ablate
crypts when given alone are not greatly
Interval between doses (h) different. The ratio "Do (drug alone):Do
G. 3. (A) Surviving fraction of crypts 3-5 (drug plus radiation)" was for HN2,
(lays after single doses ofisopropyl methane 1-7:1; for BCNU, 0 6:1; and for IMS, sulphonate (IMS). 1-5:1. The ratio for HN2 was slightly (B) Survival of erypts after 2 doses of 15:.TertofrH2wssihl
350 mg/kg IMS, at intervals of up to 24 h. surprising, in that when high split doses
were used a sparing effect had been noted
rradiation. Our results for crypt sur- (Fig. iB). Ifthis does reflect a capacity for
l after single doses of low-LET accumulation and repair of sub-lethal
iation resemble those of other workers. damage, low doses of drug might have
threshold dose before crypts were first been expected to reveal a shoulder or at
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Fi'e:. 4. Surviving fraction of crypts in mice
treated1 by toleratec( dloses of .3 alkylating
agents, followed 6 h later by a -whole-body
(lose of 1000 rad y-rays. *, IMS+y; A,
BCNU+y; *, HN2+y.
least a higher Do, as for BCNU. We have
assumed that there was no interaction
between the effects of drug and radiation,
but this has yet to be tested rigorously.
DISCUSSION
Two features of our results may be
nioted:
(A) The overall extrapolation numbers
(N) of the survival curves for cryptogenic
cells after drug treatment were lower than
those for irradiated mice of the BDF1
strain (Hendry & Potten, 1974). When
the N and RF values for each drug were
used to calculate the number of crypto-
genic cells, the results implied the existence
of only one or a few cryptogenic cells per
murine jejunal crypt. These values are at
least one order of magnitude lower than
results for cryptogenic cell number as-
sayed by whole-body irradiation (Hendry
& Potten, 1974; Potten & Hendry, 1975;
Masuda et al., 1977).
(B) Derived Do values for curves of
cryptogenic cell survival after low or high
doses of drug were broadly similar.
Ofthe factors involved in the calculation
of cryptogenic cell number, it seems
probable that the sparing effect of split
doses of HN2 and BCNU does represent
the repair of alkylating damage to DNA.
Such "repair synthesis" has been shown
for mammalian cells in vitro, treated by
drugs of all 3 classes of alkylating agent
used in the present study (Roberts et al.,
1971). However, we could not demonstrate
recovery of cryptogenic cells between
doses of IMS.
The parameter N is measured by the
intercept on the ordinate oftheexponential
part of the crypt-survival curve. The
transition from the shoulder region to the
exponential occurs when very few "stem
cells" survive per crypt (Hagemann et al.,
1971a) and these are presumed to be the
cells most resistant to the cytocidal effect
of the agent. The overall extrapolation
number divided by the RF therefore
strictly yields the number ofthese resistant
cells. Thus, the differences between the
present results and those for irradiation
may occur because the murine jejunal
crypt contains 80 (Potten & Hendry,
1975) to 140 (Masuda et al., 1977) such
cells, whereas very few cells are resistant
to the alkylating agents. Three sets of
observations may be set against this
interpretation. Firstly, we infer from our
combined-modality results that the
"sensitive" cells killed by low doses of
drug show much the same response as the
cells assayed by large doses (Table, cf. Sec-
tions A and B). Also, in a biological context
the cells assayed by large doses of HN2 or
BCNU are sensitive to the drugs. For
example, the Dos for unstimulated colony-
forming units (CFUs) of the marrow of
BDF1 mice were 3 1 mg/kg of HN2 and
36 mg/kg of BCNU (Moore, unpublished).
It seems improbable that the vast majority
of 140-150 potentially cryptogenic cells
would be uniquely sensitive to the direct
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cytotoxic action of the 3 agents used in
this study. Finally, Boarder & Blackett
(1976) have queried whether the cells
actually assayed by high single doses of
radiation represent a maximally resistant
state. They showed that pre-treatment by
arabinosyl-cytosine could further decrease
the sensitivity of cryptogenic cells to
subsequent irradiation below that for
radiation alone.
A second possible cause of disparity
between the results for drugs and radia-
tion lies in the recovery kinetics oftreated
cells. A cryptogenic cell is defined by the
capacity to regenerate into a micro-
scopically visible colony of epithelial cells
in the 3-4 days after a high dose of cyto-
toxic agent. At the doses needed to reduce
crypt survival to the exponential part of
the curve, gut death intervenes shortly
thereafter in at least some of the animals
(e.g. the LD50/5 for y-irradiated BDF1 mice
is -'1000 rad). Any treatment that delays
the onset of regeneration from a crypto-
genic cell could result in a colony too small
to be scored. Hagemann & Concannon
(1973) have shown for actinomycin D, and
Burholt et al. (1975) for adriamycin, that
prior treatment by these drugs delays the
onset of regrowth of irradiated crypts.
When given immediately before 1000 rad
ofX-rays, 10 mg/kg ofadriamycin delayed
the proliferative response by -,2 days
(Burholt et al., 1975). Even higher doses
ofadriamycin are required to ablate crypts
when the drug is given alone (Moore, un-
published). This explanation leads to the
possibility ofqualitative differences among
the cells of the cryptogenic compartment,
in their capacity to respond to treatment
by undergoing immediate and repeated
division. Alternatively, different agents
might cause different numbers of poten-
tially cryptogenic cells to move into a
non-clonogenic compartment, cf. the
"loss" of CFUs in treated marrow when
assay is delayed rather than immediate
(van Putten & Lelieveld, 1970).
The relationship of the epithelial cells
of an undamaged crypt to the morpho-
logically unidentified cryptogenic cells,
defined by an assay that relies on severe
damage to the crypt, remains uncertain.
It seems probable that the cryptogenic
cells assayed by irradiation must include
some ofthe proliferative cells ofthe normal
crypt (Potten & Hendry, 1975; Boarder
& Blackett, 1976), whereas the present
results imply the existence of only one or
a few drug-resistant cells with sufficient
proliferative capacity to be recognized by
this assay. The recent finding of Hamilton
(1978), that despite a large proliferative
compartment, the crypts of the colon of
C57B1 mice contain only 2 cryptogenic
cells when assayed by irradiation, under-
lines the complexity of interpretation of
results from the gut-microcolony assay.
Thus, the number of cells capable of pro-
ducing a microcolony might vary not only
with the cytotoxic agent used, but also
with the immediate milieu of the target
cells (e.g. through cell-cell interactions in
the highly organized structure of the
crypt).
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